Summary
Steven Tinsley is an analytics lead and life-sciences specialist with nine years’ experience translating complex biological data into commercial insight across big pharma and consulting, currently seconded into Analytics at AstraZeneca. Trained as a PhD scientist in acute myeloid leukaemia, he pairs hands-on wet-lab expertise (flow cytometry, PCR, cloning, cell culture) with rigorous market and competitive intelligence to inform drug development and customer strategies. His roles at AstraZeneca, Novartis and BTG show a track record of moving from technical analysis to strategic insight and stakeholder-facing decision support. Comfortable bridging science, analytics and commercial functions, he frequently turns clinical and molecular complexity into clear, actionable recommendations. Based in London, he brings a curiosity-driven mindset—having reframed programming as an inward journey—that aids creative problem solving beyond standard analytics playbooks.
9 years of coding experience
5 years of employment as a software developer
Master of Science (MSc) Stem cell technology, Master of Science (MSc) Stem cell technology at University of Nottingham
University College London
English